Gregory Klein

A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

Susanne Ostrowitzki, Robert Lasser, Ernest Dorflinger et al. · Alzheimer s Research & Therapy · 2017 · 568 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

Ruth Chia, Marya S. Sabir, Sara Bandrés‐Ciga et al. · Nature Genetics · 2021 · 481 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease

Rik Ossenkoppele, Ruben Smith, Niklas Mattsson et al. · JAMA Neurology · 2021 · 312 citations · Full text

Medicine, Neurology, Neuroscience +17

Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease

Randall J. Bateman, Janice Smith, Michael Donohue et al. · New England Journal of Medicine · 2023 · 280 citations · Full text

Medicine, Neurology, Neuroscience +17

Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders

Antoine Leuzy, Ruben Smith, Rik Ossenkoppele et al. · JAMA Neurology · 2020 · 240 citations · Full text

Medicine, Neurology, Nuclear Medicine +17